SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-23-017302
Filing Date
2023-08-30
Accepted
2023-08-30 17:15:01
Documents
15
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6626
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8134
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 397813
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 543
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 732
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 752
7 EXHIBIT 99.6 exhibit99-6.htm EX-99.6 3354
8 GRAPHIC exhibit99-1x001.jpg GRAPHIC 4087
9 GRAPHIC exhibit99-2x001.jpg GRAPHIC 6328
10 GRAPHIC exhibit99-2x002.jpg GRAPHIC 4054
11 GRAPHIC exhibit99-3x001.jpg GRAPHIC 124573
12 GRAPHIC exhibit99-4x001.jpg GRAPHIC 204747
13 GRAPHIC exhibit99-4x002.jpg GRAPHIC 183142
14 GRAPHIC exhibit99-5x001.jpg GRAPHIC 179862
15 GRAPHIC exhibit99-5x002.jpg GRAPHIC 181179
  Complete submission text file 0001062993-23-017302.txt   1643301
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 231226101
SIC: 2836 Biological Products, (No Diagnostic Substances)